跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APIBAX apixaban 5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
APIBAX apixaban 5 mg tablet blister pack
Approved
STANDARD
APIBAX apixaban 5 mg tablet blister pack
Nova Pharmaceuticals Australasia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
1ee481b6f7c99335
Company
Nova Pharmaceuticals Australasia Pty Ltd
Type
Standard
Approval Details
Approval Id
1ee481b6f7c99335
Product Name
APIBAX apixaban 5 mg tablet blister pack
Artg Id
428661
Artg Name
APIBAX apixaban 5 mg tablet blister pack
Sponsor
Nova Pharmaceuticals Australasia Pty Ltd
Company Detail Path
/organization/nova-pharmaceuticals-australasia-pty-ltd
Artg Date
2024-12-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/270402d679331dee90c118e26d49d360.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
1ee481b6f7c99335
Type
Standard
Back to TGA Approvals